14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
KRP vs VET: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
KRP Overall Winner
6-Pillar Tally: KRP 3 – 3 VET
Matrix Metrics: KRP 7 – 3 VET
As of Nov 20, 2026, Kimbell Royalty Partners, LP Common Units representing Limited Partner Interests (KRP) is the stronger overall head-to-head candidate over Vermilion Energy Inc. (VET) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). KRP carries a Unified Composite Score of 54.6/100 (HOLD) at $14.06 (14.4x Forward P/E, 38.0% operating margin), whereas VET carries 71.1/100 (BUY) at $10.25 (17.4x Forward P/E, -0.7% operating margin).
Composite vs. Pillar Nuance: While VET currently prints a higher short-term Unified Composite Score (71.1/100 BUY vs. KRP 54.6/100 HOLD), KRP captures the overall institutional head-to-head verdict (7–3 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (38.0% vs. -0.7% operating margin) and revenue trajectory (+28.9% vs. +30.4% YoY).
Technical & Structure Timing Caution: KRP trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 28.2); meanwhile VET is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 33.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on KRP vs VET. Trailing 12-month operating profitability (KRP 38.0% vs VET -0.7%) and valuation multiples (KRP 14.4x vs VET 17.4x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Oil & Gas E&P value chain with $2.1B market capitalization and 38.0% operating margin.
OpEx & R&D Reinvestment55.1% of Rev ($202M)
90D Engineering Disclosures0 Published
VET Moat ProfileCyclical / Execution-Driven Positioning
Oil & Gas E&P Operator
Competes within the Oil & Gas E&P value chain with $1.6B market capitalization and -0.7% operating margin.
OpEx & R&D Reinvestment64.7% of Rev ($1.27B)
90D Engineering Disclosures0 Published
Investor FAQ KRP vs VET Key Questions & Quantitative Answers
As of Nov 20, 2026, Kimbell Royalty Partners, LP Common Units representing Limited Partner Interests (KRP) is the stronger overall head-to-head candidate over Vermilion Energy Inc. (VET) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). KRP carries a Unified Composite Score of 54.6/100 (HOLD) at $14.06 (14.4x Forward P/E, 38.0% operating margin), whereas VET carries 71.1/100 (BUY) at $10.25 (17.4x Forward P/E, -0.7% operating margin). Composite vs. Pillar Nuance: While VET currently prints a higher short-term Unified Composite Score (71.1/100 BUY vs. KRP 54.6/100 HOLD), KRP captures the overall institutional head-to-head verdict (7–3 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (38.0% vs. -0.7% operating margin) and revenue trajectory (+28.9% vs. +30.4% YoY). Technical & Structure Timing Caution: KRP trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 28.2); meanwhile VET is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 33.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
VET leads the Growth & Scale pillar: KRP posts +28.9% YoY revenue growth and -35.7% YoY earnings growth on $367M TTM revenue (93.1% gross margin, 38.0% operating margin), compared with VET at +30.4% YoY revenue growth and -94.9% YoY earnings growth on $1.97B TTM revenue (64.0% gross margin, -0.7% operating margin). On trailing 12-month operating scale, KRP generates $367M in USD-normalized revenue versus $1.97B for VET. In operating R&D and SG&A reinvestment, KRP deploys 55.1% of Rev ($202M) (0 90-day corporate R&D disclosures) versus 64.7% of Rev ($1.27B) (0 disclosures) for VET.
KRP screens cheaper on headline valuation multiples. KRP trades at 14.4x Forward P/E, 18.0x Trailing P/E, 2.60x PEG, and 5.7x EV/Revenue (71.8% EBITDA margin), whereas VET trades at 17.4x Forward P/E, 17.4x Trailing P/E, 3.58x PEG, and 1.4x EV/Revenue (66.5% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against KRP (11.2% ROE) versus VET (-20.1% ROE) capital efficiency.
In options market volatility and institutional positioning, KRP carries 16.2% implied volatility (1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.29β · 30% Vol realized risk). By comparison, VET carries 46.5% implied volatility (23rd %ile, Compressed (<25th %ile)), a 0.30x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.77β · 61% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.